Growth Disorders
Recent clinical, regulatory, research and industry developments relating to this disease.
Long-Acting Growth Hormone Therapy in Pediatric Growth Hormone Deficiency: A Consensus Statement.
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
Clinical trials
The current development programme across all trial phases.
Research activity
Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.
Major themes3
- Growth Disorders1
- Hormone Replacement Therapy1
- Human Growth Hormone1
Leading journals1
- The Journal of clinical endocrinology and metabolism1
Leading researchers8
- Collett-Solberg PF1
- Cutfield W1
- Dattani M1
- Deal C1
- Horikawa R1
- Maghnie M1
- Maniatis A1
- Miller BS1
Affiliations (unnormalised)6
- Centre de recherche CHU Ste-Justine1
- Friedrich-Alexander-University (FAU) Erlangen-Nürnberg1
- Hôpital Universitaire Necker Enfants Malades1
- Karolinska Institutet and Karolinska University Hospital1
- Liggins Institute1
- Maternal and Child Health University of Genova1
Reference
Authoritative identity, definition & identifiers.
Deviations from the average values for a specific age and sex in any or all of the following: height, weight, skeletal proportions, osseous development, or maturation of features. Included here are both acceleration and retardation of growth.
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
- Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
- Related entities are derived from literature co-mention (studied together) — associative, not causal.